---
document_datetime: 2023-09-21 21:39:35
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lupkynis-epar-all-authorised-presentations_en.pdf
document_name: lupkynis-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7035197
conversion_datetime: 2025-12-20 16:24:11.470953
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number                         | (Invented) name   | Strength      | Pharmaceutical Form         | Route of Administration   | Immediate Packaging                 | Pack size                 |
|-----------------------------------|-------------------|---------------|-----------------------------|---------------------------|-------------------------------------|---------------------------|
| EU/1/22/1678/001 EU/1/22/1678/002 | Lupkynis Lupkynis | 7.9 mg 7.9 mg | Capsule, soft Capsule, soft | Oral use Oral use         | Blister (alu/PVC) Blister (alu/PVC) | 180 capsules 576 capsules |